AVITA Medical (AVHHL) Cash from Operations (2019 - 2025)

AVITA Medical (AVHHL) has reported Cash from Operations for 7 consecutive years, with -$5.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations rose 32.32% year-over-year to -$5.4 million; the trailing twelve-month figure through Dec 2025 stood at -$31.2 million (up 36.2% YoY), and the FY2025 full-year result was -$31.2 million, up 36.2% from the prior year.
• Cash from Operations declined to -$5.4 million in Q4 2025 per AVHHL's latest filing, from -$5.2 million in the prior quarter.
• Across five years, Cash from Operations topped out at $6.8 million in Q4 2022 and bottomed at -$20.9 million in Q1 2024.
• Historically, Cash from Operations has averaged -$9.1 million across 5 years, with a median of -$9.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Cash from Operations sank 258.7% in 2023, then surged 50.59% in 2025.
• Over 5 years, Cash from Operations stood at -$13.1 million in 2021, then jumped by 152.14% to $6.8 million in 2022, then tumbled by 258.7% to -$10.9 million in 2023, then advanced by 25.97% to -$8.0 million in 2024, then soared by 32.32% to -$5.4 million in 2025.
• According to Business Quant data, Cash from Operations over the past three periods registered -$5.4 million, -$5.2 million, and -$10.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.